BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30997344)

  • 1. Influence of genetic copy number variants of the human GLUT3 glucose transporter gene
    Simpfendorfer KR; Li W; Shih A; Wen H; Kothari HP; Einsidler EA; Wuster A; Hunkapiller J; Behrens TW; Graham RR; Townsend MJ; Behar DM; Hu R; Greenspan E; Gregersen PK
    Mol Genet Metab Rep; 2019 Jun; 19():100470. PubMed ID: 30997344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3.
    Veal CD; Reekie KE; Lorentzen JC; Gregersen PK; Padyukov L; Brookes AJ
    Hum Mutat; 2014 Feb; 35(2):248-56. PubMed ID: 24178905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular effects and clinical implications of SLC2A3 copy number variation.
    Ziegler GC; Almos P; McNeill RV; Jansch C; Lesch KP
    J Cell Physiol; 2020 Dec; 235(12):9021-9036. PubMed ID: 32372501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.
    Merker S; Reif A; Ziegler GC; Weber H; Mayer U; Ehlis AC; Conzelmann A; Johansson S; Müller-Reible C; Nanda I; Haaf T; Ullmann R; Romanos M; Fallgatter AJ; Pauli P; Strekalova T; Jansch C; Vasquez AA; Haavik J; Ribasés M; Ramos-Quiroga JA; Buitelaar JK; Franke B; Lesch KP
    J Child Psychol Psychiatry; 2017 Jul; 58(7):798-809. PubMed ID: 28224622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and experimental validation of ferroptosis-related gene SLC2A3 is involved in rheumatoid arthritis.
    Xiang J; Chen H; Lin Z; Chen J; Luo L
    Eur J Pharmacol; 2023 Mar; 943():175568. PubMed ID: 36736942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of multiple human iPSC lines from peripheral blood mononuclear cells of two SLC2A3 deletion and two SLC2A3 duplication carriers.
    Ziegler GC; Radtke F; Vitale MR; Preuße A; Klopocki E; Herms S; Lesch KP
    Stem Cell Res; 2021 Oct; 56():102526. PubMed ID: 34492570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural Deletion of Glucose Transporter Isoform 3 Creates Distinct Postnatal and Adult Neurobehavioral Phenotypes.
    Shin BC; Cepeda C; Estrada-Sánchez AM; Levine MS; Hodaei L; Dai Y; Jung J; Ganguly A; Clark P; Devaskar SU
    J Neurosci; 2018 Oct; 38(44):9579-9599. PubMed ID: 30232223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice.
    Schmidt S; Richter M; Montag D; Sartorius T; Gawlik V; Hennige AM; Scherneck S; Himmelbauer H; Lutz SZ; Augustin R; Kluge R; Ruth P; Joost HG; Schürmann A
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1084-94. PubMed ID: 18780771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC2A3 rs12842 polymorphism and risk for Alzheimer's disease.
    Arseniou S; Siokas V; Aloizou AM; Stamati P; Mentis AA; Tsouris Z; Dastamani M; Peristeri E; Valotassiou V; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
    Neurol Res; 2020 Oct; 42(10):853-861. PubMed ID: 32627711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate-mediated Resistance to Trichostatin A Accompanied by Elevated Expression of Glucose Transporter 3 (GLUT3) in Human Colorectal Carcinoma HCT116 Cells.
    Khonthun C; Surangkul D
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4085-4092. PubMed ID: 38156841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.
    Ryniawec JM; Coope MR; Loertscher E; Bageerathan V; de Oliveira Pessoa D; Warfel NA; Cress AE; Padi M; Rogers GC
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.
    Vittori A; Breda C; Repici M; Orth M; Roos RA; Outeiro TF; Giorgini F; Hollox EJ;
    Hum Mol Genet; 2014 Jun; 23(12):3129-37. PubMed ID: 24452335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription.
    Ha TK; Chi SG
    Autophagy; 2012 Nov; 8(11):1684-5. PubMed ID: 22874559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.
    Mlynarski EE; Sheridan MB; Xie M; Guo T; Racedo SE; McDonald-McGinn DM; Gai X; Chow EW; Vorstman J; Swillen A; Devriendt K; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Philip N; Simon TJ; Roberts AE; Piotrowicz M; Bearden CE; Eliez S; Gothelf D; Coleman K; Kates WR; Devoto M; Zackai E; Heine-Suñer D; Shaikh TH; Bassett AS; Goldmuntz E; Morrow BE; Emanuel BS;
    Am J Hum Genet; 2015 May; 96(5):753-64. PubMed ID: 25892112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.
    Masin M; Vazquez J; Rossi S; Groeneveld S; Samson N; Schwalie PC; Deplancke B; Frawley LE; Gouttenoire J; Moradpour D; Oliver TG; Meylan E
    Cancer Metab; 2014; 2():11. PubMed ID: 25097756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of glucose transporter GLUT3 for post-implantation embryonic development.
    Schmidt S; Hommel A; Gawlik V; Augustin R; Junicke N; Florian S; Richter M; Walther DJ; Montag D; Joost HG; Schürmann A
    J Endocrinol; 2009 Jan; 200(1):23-33. PubMed ID: 18948350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.
    Dai DW; Lu Q; Wang LX; Zhao WY; Cao YQ; Li YN; Han GS; Liu JM; Yue ZJ
    BMC Cancer; 2013 Oct; 13():478. PubMed ID: 24124917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A.
    Mimura I; Nangaku M; Kanki Y; Tsutsumi S; Inoue T; Kohro T; Yamamoto S; Fujita T; Shimamura T; Suehiro J; Taguchi A; Kobayashi M; Tanimura K; Inagaki T; Tanaka T; Hamakubo T; Sakai J; Aburatani H; Kodama T; Wada Y
    Mol Cell Biol; 2012 Aug; 32(15):3018-32. PubMed ID: 22645302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.
    Rodriguez-Rodriguez L; Ivorra-Cortes J; Carmona FD; Martín J; Balsa A; van Steenbergen HW; van der Helm-van Mil AH; González-Álvaro I; Fernandez-Gutiérrez B
    Arthritis Res Ther; 2015 Nov; 17():306. PubMed ID: 26538147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation.
    Fidler TP; Middleton EA; Rowley JW; Boudreau LH; Campbell RA; Souvenir R; Funari T; Tessandier N; Boilard E; Weyrich AS; Abel ED
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1628-1639. PubMed ID: 28663252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.